ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
41.07
0.02%
US Tech 100
21,068.40
0.04%
S&P 500
6,090.27
0.25%
US Dollar vs CAD
1.41408
-0.12%
Bitcoin
98,442.28
-2.76%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Oxford Biodynamics Plc (OBD) Share Price

Oxford Biodynamics Plc

Oxford Biodynamics Plc (OBD)

LSE
1.25
0.00
( 0.00% )
Updated: 02:12:45
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.25
Bid
1.30
Ask
1.48
Volume
50,045
0.00 Day's Range 0.00
1.00 52 Week Range 36.50
Market Cap
3.898M
Previous Close
1.25
Open
-
Last Trade
4244
@
1.33
(O)
Last Trade Time
02:19:51
Financial Volume
-
VWAP
-
Average Volume (3m)
4,801,992
Shares Outstanding
311,860,000
Dividend Yield
-
PE Ratio
-0.36
Earnings Per Share (EPS)
-0.03
Revenue
1.34M
Net Profit
-10.83M

About Oxford Biodynamics Plc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.oxfordbiodynamics.com
Headquarters
Oxford, Gbr
Founded
-
Oxford Biodynamics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker OBD. The last closing price for Oxford Biodynamics was 1.25p. Over the last year, Oxford Biodynamics shares have traded in a share price range of 1.00p to 36.50p.

Oxford Biodynamics currently has 311,860,000 shares outstanding. The market capitalization of Oxford Biodynamics is £3.90 million. Oxford Biodynamics has a price to earnings ratio (PE ratio) of -0.36.

Ask ADVFN Intelligence (AI)

OBD Latest News

More News

Oxford BioDynamics PLC Holding(s) in Company

Oxford BioDynamics PLC 06 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft...

December 06 2024
RNS Regulatory News

Oxford BioDynamics PLC Response to Share Price Movement

Oxford BioDynamics PLC 03 December 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group")   Response to Share Price Movement   Oxford, UK - 3...

December 03 2024
RNS Regulatory News

Oxford BioDynamics PLC Director/PDMR Shareholding

Oxford BioDynamics PLC 29 November 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") Issue of shares in lieu of salary, Director / PDMR...

November 29 2024
RNS Regulatory News

Oxford BioDynamics PLC Director / PDMR holdings and Total Voting Rights

Oxford BioDynamics PLC 28 October 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") Issue of shares in lieu of salary, Director / PDMR...

October 28 2024
RNS Regulatory News

Oxford BioDynamics PLC Prognostic Covid Severity Test Study Published

Oxford BioDynamics PLC 25 October 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") EpiSwitch Prognostic Covid Severity Test Study Published...

October 25 2024
RNS Non-Regulatory

Oxford BioDynamics PLC CiRT Receives Clinical Approval from NYS CLEP

Oxford BioDynamics PLC 22 October 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group") EpiSwitch® CiRT Receives Clinical Approval from  New York...

October 22 2024
RNS Non-Regulatory

Oxford BioDynamics PLC Holding(s) in Company

Oxford BioDynamics PLC 15 October 2024     TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in...

October 15 2024
RNS Regulatory News

Oxford BioDynamics pledges to cut costs amid need to raise extra funds

Oxford BioDynamics PLC on Monday launched a strategic review after warning it would need additional cash resources by ...

October 14 2024
Alliance News

Oxford BioDynamics PLC Commercial update for FY24

Oxford BioDynamics PLC 14 October 2024   Oxford BioDynamics ("OBD" or the "Company" and, together with its subsidiaries, the "Group")   Commercial update on financial year ended 30 September...

October 14 2024
RNS Regulatory News

Oxford BioDynamics PLC Holding(s) in Company

Oxford BioDynamics PLC 07 October 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BD5H8572 Issuer Name OXFORD BIODYNAMICS PLC UK or Non-UK Issuer UK...

October 07 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.11-8.088235294121.362.21.20548062371.69675078DE
4-0.13-9.420289855071.382.21.1519403841.52013002DE
12-3.4-73.11827956994.654.65148019921.59146201DE
26-6.45-83.76623376627.78.4128131032.40879177DE
52-24.95-95.229007633626.236.5118139795.09322696DE
156-37.65-96.786632390738.951194053713.03872094DE
260-109.75-98.8738738739111125160881617.38247649DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STKStreaksai Plc
0.70p
(33.33%)
5.02M
OMIOrosur Mining Inc
6.90p
(28.25%)
6.17M
CORCorpus Resources Plc
0.0285p
(26.67%)
59.78M
GNIPGenip Plc
26.50p
(23.26%)
139.02k
GRLGoldstone Resources Limited
1.125p
(18.42%)
2.89M
VALValirx Plc
0.75p
(-50.00%)
2.97M
WSBNWishbone Gold Plc
0.235p
(-18.97%)
2.45M
CRTACirata Plc
31.05p
(-15.57%)
296.93k
SPECInspecs Group Plc
41.00p
(-15.46%)
646.14k
TXPTouchstone Exploration Inc
23.75p
(-15.18%)
2.35M
NTVONativo Resources Plc
0.0023p
(-8.00%)
1.16B
SYMESupply@me Capital Plc
0.0043p
(16.22%)
220.85M
ORCPOracle Power Plc
0.036p
(0.00%)
202.16M
VRSVersarien Plc
0.0382p
(14.03%)
110.79M
TRPTower Resources Plc
0.028p
(-1.75%)
88.2M

Discussion

View Full Feed
TrendTrade2016 TrendTrade2016 6 minutes ago
AISP BREAKIN 4 BUCKS
AISP
TrendTrade2016 TrendTrade2016 8 minutes ago
BEEN SCHOOLING THIS CLOWN FOR YEARS...
QBTS
TrendTrade2016 TrendTrade2016 10 minutes ago
QBTS 6 BUCKS NEXT
QBTS
GolfnutBoston GolfnutBoston 12 minutes ago
Buy quantum computing stocks. Most are up 400-1000% the past month or so. 
AFFU
brown4321 brown4321 15 minutes ago
Praying for this maybe next year before Christmas
QOIL
cojoboy cojoboy 17 minutes ago
Well.sometimes I make money..sometime not..still don't know what your gibberish means..??
IGPK
fuagf fuagf 18 minutes ago
dbergh, No one cries for you heartlessness. A decade from now you
might understand how cruel, and how out of touch, you have been.
brown4321 brown4321 18 minutes ago
I’m praying everyday
VGID
cojoboy cojoboy 20 minutes ago
Well.not sure how that addresses my idiot status.???
IGPK
TrendTrade2016 TrendTrade2016 21 minutes ago
SATL BREAKING 5 BUCKS IN PRE
SATL
TrendTrade2016 TrendTrade2016 22 minutes ago
RGTI GAPPING HARD
RGTI
TrendTrade2016 TrendTrade2016 23 minutes ago
SATL GAPPING HARD
SATL
Bull_Dolphin Bull_Dolphin 24 minutes ago
Cuteness Overload:

https://x.com/damescorpio/status/1864386165266055356
TrendTrade2016 TrendTrade2016 26 minutes ago
QBTS GAPPING UP...
QBTS
BIOCHEMUP BIOCHEMUP 27 minutes ago
5.6 in pm.
QBTS
Wolf-man jack Wolf-man jack 35 minutes ago
WQLF SAYS: Thank YQU JD. Our Third AcQuisition is going to be a Charm WE Do Understand YQU Understand. Have Mercy Have Faith Have Patience Have International Partners Have M&A’s Have AcQuisition of CV Sciences by Deep Pockets WQLF Ahooooooo

CBD Products

CBG Products
CVSI
bones jones bones jones 44 minutes ago
This surely is the right stock for long term, although I will be selling some on the way up 1-2 bucks not pennies!
RDAR
DocLee DocLee 51 minutes ago
2 LIES, Hygro, in 1 sentence - pretty good going even for you. PFS was the PRIMARY endpoint of the trial and DCVax-L failed to meet it. Progression-free Survival (PFS) was an INITIAL endpoint of the trial but it was found to be indistinguishable from a strong immunological response with the
NWBO
Hugie Hugie 57 minutes ago
Really ? How do you know ? Not any reason for this move yet.
ZHUD
Konaploinks Konaploinks 1 hour ago
Doc. I stand corrected. They just had the filed date. I see it was granted on Dec 3 2024. Mahalo
IONQ

Your Recent History

LSE
OBD
Oxford Biodynamics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved